Does PANTOPRAZOLE Cause Hepatic steatosis? 249 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 249 reports of Hepatic steatosis have been filed in association with PANTOPRAZOLE (Pantoprazole Sodium). This represents 0.3% of all adverse event reports for PANTOPRAZOLE.
249
Reports of Hepatic steatosis with PANTOPRAZOLE
0.3%
of all PANTOPRAZOLE reports
5
Deaths
123
Hospitalizations
How Dangerous Is Hepatic steatosis From PANTOPRAZOLE?
Of the 249 reports, 5 (2.0%) resulted in death, 123 (49.4%) required hospitalization, and 3 (1.2%) were considered life-threatening.
Is Hepatic steatosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PANTOPRAZOLE. However, 249 reports have been filed with the FAERS database.
What Other Side Effects Does PANTOPRAZOLE Cause?
Chronic kidney disease (28,127)
Acute kidney injury (15,961)
Renal failure (11,543)
End stage renal disease (8,523)
Renal injury (7,070)
Drug ineffective (5,487)
Off label use (4,279)
Pain (4,057)
Dyspnoea (4,052)
Fatigue (3,797)
What Other Drugs Cause Hepatic steatosis?
METHOTREXATE (1,400)
ADALIMUMAB (1,058)
ETANERCEPT (620)
TOCILIZUMAB (476)
TOFACITINIB (405)
LEFLUNOMIDE (359)
HYDROXYCHLOROQUINE (358)
ABATACEPT (345)
METFORMIN (343)
INFLIXIMAB (325)
Which PANTOPRAZOLE Alternatives Have Lower Hepatic steatosis Risk?
PANTOPRAZOLE vs PANTOPRAZOLE ANHYDROUS
PANTOPRAZOLE vs PANTOTHENIC ACID
PANTOPRAZOLE vs PAPAVERINE
PANTOPRAZOLE vs PARACETAMOL
PANTOPRAZOLE vs PARATHYROID HORMONE